Connect with us

Uncategorized

Vic Falls tour companies reel from lockdown

Published

on

BY NOKUTHABA DLAMINI

Tour companies in Victoria Falls are counting the costs after the latest lockdown to slow down the spread of Covid-19 saw both local and international tourists cancelled their bookings.

Advertisement

President Emmerson Mnangagwa imposed a strict lockdown last month after Zimbabwe was hit by a third wave of the Covid-19 outbreak.

Clement Mukwasi, Employers Association for Tours and Safari Operators (EASTSO) president, told VicFallsLive the lockdown restrictions that include a ban on intercity travel had left tour companies battling for survival.

 “The little candle that had already started showing itself was immediately blown off and we are in the dark again,” Mukwasi said.

Advertisement

“It was for a good reason, but we were plunged into problems as there are no activities and hotel bookings..

“We had significant, but low bookings that had been registered and they immediately cancelled because of these restrictions.”

The tourism industry has been operating at 20 percent of its capacity last year and there is no hope of an improvement soon, Explore Zimbabwe’s Peggie White noted.

Advertisement

“As safari operators doing guided tours around Hwange National Park and Victoria Falls, the effects of Covid-19 have been beyond one’s imagination,” White said.

“We thought things were going to be better after a year and right now we are witnessing many (Covid-19) positive cases being recorded and people especially those from India and America have rescheduled and that keeps plunging the destination into uncertainty.

Authorities in the tourism industry say the country lost more than US$ 1.6 billion worth of revenue in 2020 alone following the outbreak of Covid-19 and the subsequent border closures.

Advertisement

Zimbabwe’s tourism sector generally brings in between US$1.5 million and US$ 2 billion annually.

Mukwasi said tour companies were now shifting their focus to domestic tourism.

“Our focus now has now been at the domestic tourism more than international tourism because of the new normal that we are now living in,” he added.

Advertisement

“The restrictions that came as a result of trying to curb the third wave keep on impacting quite seriously on the industry as a whole, but we have got some hope that after the lockdown and when more people have taken the vaccines, we are likely to then see the business starting to kick again.

“That, however, should be guided by opening responsibly because vaccines alone will not remove the scourge.

Advertisement
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

National

Zimbabwe fast-tracks approval of long-acting HIV prevention drug Lenacapavir

Published

on

BY WANDILE TSHUMA

Zimbabwe has taken a major step in the fight against HIV following the rapid approval of Lenacapavir, a groundbreaking long-acting injectable for HIV pre-exposure prophylaxis (PrEP). The Medicines Control Authority of Zimbabwe (MCAZ) authorised the drug in just 23 days, marking one of the fastest regulatory approvals in the country’s history.

The application, submitted by pharmaceutical company Gilead Sciences in October, underwent an expedited review because of its public health importance. MCAZ says the fast-tracked process did not compromise scientific scrutiny, with the product subjected to a rigorous assessment of its safety, efficacy and quality.

Lenacapavir is designed for adults and adolescents weighing at least 35kg who are HIV-negative but at substantial risk of infection. Unlike traditional daily oral PrEP, the medicine is administered as a six-monthly injection, following an initiation phase that includes one injection and oral tablets on Days 1 and 2. Health authorities say this long-acting formulation could dramatically improve adherence and expand prevention options, particularly for communities where daily pill-taking is difficult.

MCAZ Director-General  Richard T. Rukwata described the approval as a landmark moment in Zimbabwe’s HIV response.

“The rapid approval of Lenacapavir reflects MCAZ’s dedication to accelerating access to trusted, high-quality health products. This milestone brings new hope for HIV prevention and reinforces our commitment to safeguarding public health,” he said.

To fast-track the process, the Authority applied a regulatory reliance approach, drawing on scientific assessments from the World Health Organization’s Prequalification Programme (WHO PQ). This allowed evaluators to build on internationally recognised review processes while ensuring Zimbabwe’s own standards were met.

The introduction of Lenacapavir comes as Zimbabwe continues efforts to reduce new HIV infections, particularly among young people and key populations who face barriers to consistent PrEP use. Public health experts say the drug’s twice-yearly dosing could be a game changer in improving uptake and protection.

MCAZ says it remains committed to ensuring Zimbabweans have access to safe, effective and good-quality medical products, in line with its mandate under the Medicines and Allied Substances Control Act.

Continue Reading

Slider

ZimParks to host first-ever International Wildlife Conservation symposium

Published

on

BY NOKUTHABA DLAMINI

The Zimbabwe Parks and Wildlife Management Authority (ZimParks) will hold its inaugural International Wildlife Conservation Symposium under the theme “Wildlife Conservation and Sustainable Development.”

The two-day event, scheduled for October 22 to 23, next week, will take place at the Management Training Bureau in Msasa, Harare. It will bring together conservationists, researchers, policymakers, and students to discuss key issues around wildlife protection and sustainable development.

The symposium will focus on eight sub-themes, namely Wildlife Conservation and Transboundary Management, Freshwater, Fisheries and Aquatic Management, Sustainable Tourism and Socio-Economic Development, Human-Wildlife Interactions, Environmental Health and Safety, Climate Change Adaptation and Mitigation, Community-Based Natural Resource Management, and Natural Resource Policy and Governance.

ZimParks says the symposium will provide a platform to exchange ideas and deepen understanding of the link between wildlife conservation and sustainable development. Members of the public, students, and professionals are encouraged to attend.

 

Continue Reading

National

CCC legislators in road accident, Nkulumane MP dies

Published

on

BY STAFF REPORTER

One Citizens Coalition for Change (CCC) legislator has died while four others were seriously injured in a road accident that occurred early Friday morning near Shangani along Bulawayo-Harare highway.

CCC spokesperson Promise Mkhwananzi confirmed the accident, saying it happened between 2 a.m. and 3 a.m. when the vehicle carrying the members collided with an elephant.

“The vehicle hit an elephant along the Shangani area, and unfortunately Honourable Desire Moyo, the Member of Parliament for Ngulumane, died on the scene,” Nkwananzi said.

He added that the other occupants — Honourable Madalaboy Ndebele, Senator Rittah Ndlovu, Honourable Sethulo Ndebele, and Libion Sibanda — sustained serious injuries and were rushed to a hospital in Bulawayo.

Nkwananzi said he was deeply shocked by Moyo’s death, as he had met him just yesterday in Harare.

“I had seen Moyo yesterday and we spent about an hour chatting outside Jamieson Hotel about the party and our future plans for national development,” he said. “I’m gutted by his passing. It’s a huge loss for the party.”

He conveyed his condolences to the Moyo family and wished a speedy recovery and strength to the families of the other CCC members who remain in critical condition.

He said further details, including the name of the hospital where the injured are receiving treatment, would be released once confirmed.

Would you like me to prepare a shorter social media version (for X or Facebook) that captures the key facts and emotion in about 3–4 sentences?

Continue Reading

Trending

Copyright © 2022 VicFallsLive. All rights reserved, powered by Advantage